An indigenously developed test that uses the cutting-edge CRISPR gene-editing technology to detect the SARS-CoV-2 virus that causes the Covid-19 infection accurately, cheaply and quickly has been approved for commercial launch by the Drugs Controller General of India. “The Tata CRISPR test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19,” said a govt statement.
